Dr DeAngelis received her MD from the University of Pittsburgh’s School of Medicine, her MPH from the Harvard Graduate School of Public Health (Health Services Administration), and her pediatric specialty training at the Johns Hopkins Hospital. She currently serves on the Advisory Committee to the Director of the NIH and the Advisory Board of the Government Accounting Office – Comptroller General. Dr DeAngelis oversees JAMA, nine Archives publications and JAMA related website content. Before her appointment, she was vice dean for Academic Affairs and Faculty, Johns Hopkins University School of Medicine, and from 1994-2000, she was editor of Archives of Pediatrics and Adolescent Medicine. She also served as a member of numerous journal editorial boards. She has authored 11 books on Pediatrics and Medical Education and published over 200 original articles, chapters, editorials, and abstracts. Most of her recent publications focused on conflicts of interest in medicine, on women in medicine, and on medical education. Dr DeAngelis, a former council member of the National Academy of Science, Institute of Medicine, a Fellow of the American Association for the Advancement of Science, and has served as an officer of numerous national academic societies including past chairman of the American Board of Pediatrics and Chair of the Pediatric Accreditation Council for Residency Review Committee of the American Council on Graduate Medical Education. |
Writing Workshop 1A: Writing Workshop 2A: |
Dr Fontanarosa is the Executive Deputy Editor of JAMA, The Journal of the American Medical Association, and is Vice-President of Scientific Publications and Multimedia Applications at the American Medical Association. Dr. Fontanarosa has been an editor at JAMA since 1993, and has been the Executive Deputy Editor since 2000. Dr. Fontanarosa received his Medical Degree from the Medical College of Ohio, is board certified in Emergency Medicine, and received an MBA from the University of Notre Dame. Dr. Fontanarosa is an Adjunct Professor at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. |
Writing Workshop 1B: Writing Workshop 2B: |
Dr Norman Chan graduated from Liverpool University, UK in 1991, and underwent his postgraduate training in London. He obtained his MRCP in 1994, and went on to complete his specialist training in Diabetes & Endocrinology & Metabolism in Northwest Thames, London, UK, in 2001. Dr Chan was awarded the Junior British Heart Foundation grant to conduct a 2-year research project, titled “Endothelial dysfunction, coronary artery calcification in type 1 diabetes”. This study formed the basis of his MD thesis, which was completed in 2002. With a group of professors from The Chinese University of Hong Kong and GenRx of HKR International, Dr Chan helped to establish Qualigenics Diabetes Centre in November 2002, and become its Clinical Director since 2004. Dr Chan is also the Secretary of the Hong Kong Atherosclerosis Society, as well as a member of the scientific committee of the Hong Kong Foundation of Diabetes Research and Development. |
Keynote Lecture 9: SIG Seminar 8: JAMA Article |
Dr. Katherine Flegal is a Distinguished Consultant at the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC). She is also an adjunct professor at the School of Public Health, University of North Carolina. Dr. Flegal received her undergraduate education at the University of California, Berkeley, and her Ph.D. from Cornell University. She completed a post-doctoral fellowship in alcohol epidemiology at the University of Pittsburgh. She was a research faculty member in the Biostatistics department of the University of Michigan before coming to CDC in 1987. Her primary research interests are in the epidemiology of obesity and related conditions, and she has published widely in this area. Her current interests include tracking the prevalence of obesity in the United States and investigating the association of weight with mortality. |
Keynote Lecture 1: SIG Seminar 4: JAMA Articles Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity |
David Flum, a gastrointestinal surgeon by training, is a leader in bridging clinical care and public health issues. He serves as Medical Director of the Surgical Care and Outcomes Assessment Program (SCOAP), which looks into improving the quality of and the adoption of best practices in hospital care. He is also one of the Principal Investigators of the Longitudinal Assessment of Bariatric Surgery (LABS) study-the first NIH-funded study in bariatric surgery aimed at addressing fundamental issues in the field. He contributes to Journal of the American Medical Association, serves on the editorial board of the journal Surgery for Obesity and Related Disease, and chairs the American Society of Metabolic and Bariatric Surgeons’ Research Committee. Flum completed his 6-year medical program at the University of Miami and training in surgery at New York’s St Vincent’s Hospital. He then served for three years as a Staff Surgeon in the Public Health Service on the Navajo Nation in rural Arizona before joining the University of Washington as a Robert Wood Johnson Clinical Scholar. He has a Masters in Public Health in the field of health services research. |
Keynote Lecture 6: SIG Seminar 5: JAMA Articles Early Mortality Among Medicare Beneficiaries Undergoing Bariatric Surgical Procedures |
Dr. Hirsch graduated from the University of Missouri in Columbia, MO before completing his internal medicine training at the University of Miami and Mt. Sinai Medical Center in Miami, FL. He completed his endocrinology and metabolism training at Washington University in St. Louis. An active member of the ADA, AACE, the American College of Physicians, and the American Board of Internal Medicine, he maintains an active clinical practice of which 80% of patients have type 1 diabetes. Dr. Hirsch participated in national policy implementation relating to the management of hyperglycemia in the hospitals for over 20 years. He developed strong interest in new technologies for the treatment of diabetes, using insulin therapy and in the mechanisms of insulin co-modulating inflammation with glucose and the resulting improvements in outcomes of hospitalized patients. A leader in the area of real-time continuous glucose monitoring, Dr Hirsch computerizes diabetes data management and pattern recognition to improve diabetes control, in addition to how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications. He has authored over 100 papers including a review of insulin in the New England Journal of Medicine, 40 editorials, numerous book chapters, and four books both for patients and physicians. He is the past editor-in-chief of DOC News and Clinical Diabetes. In 2001 he was awarded Young Physician of the Year by the University of Missouri, in 2004 he was awarded the Physician Clinician of the Year award by the American Diabetes Association, and in 2006 received the Distinguished Endocrinologist Award from the American Association of Clinical Endocrinologists. |
Keynote Lecture 8: SIG Seminar 6: JAMA Articles Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review and others … |
Barbara Howard received her PhD in Microbiology from the University of Pennsylvania in 1968. She currently chairs the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. She headed the Nutrition Committee of the American Heart Association, the Nutrition Study Section of the National Institutes of Health, and served as a member of the NIH Expert Panel on Obesity that developed guidelines for the treatment and prevention of obesity. Formerly, the Associate Chief of the Phoenix Clinical Diabetes and Nutrition Section, NIDDK, National Institutes of Health, she was a Bierman lecturer for the American Diabetes Association, a Levy lecturer for the American Heart Association, and has received the Kelly West Award from the American Diabetes Association. Dr Howard received the Bolton Corson Medal from the Franklin Institute for research in nutrition and atherosclerosis and the Special Recognition Award from the Arteriosclerosis Council of the American Heart Association. Her major research interests are in cardiovascular disease, in relation to diabetes and its occurrence in diverse ethnic groups. Research projects include the Strong Heart Study, a multi-center study of cardiovascular disease and its risk factors in American Indians; the Women’s Health Initiative, a multi-center study of postmenopausal women and their health; GOCADAN, a study of the genetics of coronary artery disease in Alaska Eskimos and the SANDS study, a multi-center study to examine strategies for reducing atherosclerosis in people with diabetes. She also serves on the editorial boards for several scientific journals. |
Keynote Lecture 2: SIG Seminar 1: JAMA Articles Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial and others … |
David S. Ludwig, MD, PhD, a pediatric endocrinologist, is Founding Director of the Optimal Weight for Life (OWL) clinic at Children’s Hospital, Boston. He holds the position of Associate Professor in Pediatrics at Harvard Medical School. Dr. Ludwig's research focuses on the effects of dietary composition on hormones, metabolism and body weight regulation. In particular, he has been developing a novel “low glycemic” diet (i.e., one that decreases the surge in blood sugar after meals) for the treatment of obesity and prevention of type 2 diabetes. He has published over 80 articles in medical or scientific journals including JAMA, New England Journal of Medicine and Lancet. His research is supported by grants from the National Institutes of Health and from philanthropic foundations. Described as an “obesity warrior” by Time Magazine, Dr. Ludwig has fought for fundamental policy changes to restrict food advertising directed at young children, improve quality of school nutrition programs and increase insurance reimbursement for obesity prevention and treatment programs. He has appeared frequently in the national media, including New York Times, National Public Radio, Dateline NBC and The Today Show. He is author of a book on childhood obesity for parents entitled Ending the Food Fight: Guide Your Child to a Healthy Weight in a Fast Food/Fake Food World (Houghton Mifflin, 2007). |
Keynote Lecture 4: SIG Seminar 7: JAMA Articles Sugar-Sweetened Beverages, Weight Gain, and Incidence of Type 2 Diabetes in Young and Middle-Aged Women |
Dr Pi-Sunyer, a member of the FDA Science Board Advisory Committee, received his BA in 1955 from Oberlin College and completed an MD from Columbia's College of Physicians and Surgeons in 1959 and an MPH from Harvard University School of Public Health in 1963. Dr. Pi-Sunyer was a Professor of Applied Physiology at Columbia Teachers’ College from 1985 to 2005. He has served as president of the American Diabetes Association, the American Society for Clinical Nutrition, and the North American Association for the Study of Obesity, as well as a Councillor of the Society for Experimental Biology and Medicine. He chaired the committee of the U.S. National Heart, Lung, and Blood Institute that researched and defined the federal government’s new guidelines for the prevention and treatment of obesity. Dr Pi-Sunyer has been a Fellow of the Fogarty International Center of the National Institutes of Health, and a member of various task forces within the Institute of Medicine to study Opportunities in the Nutrition and Food Sciences, Medical Nutrition Therapy and Dietary Reference Intakes on Macronutrients. He also served on the 2005 U.S. Dietary Guidelines Advisory Committee. His research focus is on carbohydrate and lipid metabolism, obesity and diabetes. He is on the Steering Committees of both the Diabetes Prevention Program and the LookAhead trials of the NIDDK. |
Keynote Lecture 10: SIG Seminar 2: JAMA Articles Weight Loss With Self-help Compared With a Structured Commercial Program: A Randomized Trial |
Dr. Saudek graduated from Harvard College and Cornell University Medical College, training in internal medicine in metabolism at Harvard Medical School. He served on the faculty at Cornell for eight years before joining the faculty of Johns Hopkins University School of Medicine, where he is currently the Hugh P. McCormick Family Professor of Medicine, Director of the Johns Hopkins Diabetes Center and Program Director of the General Clinical Research Center (GCRC). At Johns Hopkins, Dr. Saudek teaches students at all levels. He sees patients regularly, and lectures on various aspects of diabetes. With a nurse educator and behaviorist, he authored The Johns Hopkins Guide to Diabetes: for Today and Tomorrow. His research interests have varied, including early description of hemoglobin A1c as an index of blood glucose control, development of the implantable insulin pump, and a Principal Investigator of the federally funded Diabetes Prevention Program. He has been Program Director of the Hopkins General Clinical Research Center, is P.I. of a Training Grant in Diabetes and Endocrinology at Hopkins, and has been continuously funded by the NIH for over 30 years. Dr. Saudek has been active in professional organizations. He was President of the American Diabetes Association in 2001-2, and was the ADA Outstanding Clinician in 1990. He has been on various national boards, and has served on editorial boards. In his spare time, he is enthusiastic about sailing, squash, clarinet and family (not in that order). |
Keynote Lecture 3: SIG Seminar 3: JAMA Articles Progress and Promise of Diabetes Research |
Dr E Shyong Tai, trained in medicine at the University of Dundee, UK, before returning to Singapore where he trained first in internal medicine, and then as an endocrinologist at the Singapore General Hospital. He is a Member of the Royal College of Physicians in the UK, and a Fellow of the Academy of Medicine in Singapore (Endocrinology). Dr Tai's major research interests revolve around diabetes mellitus, dyslipidemia, and their relations with atherosclerotic disease. He is involved in several large studies examining the role of genetic and environmental factors and their interactions in the pathogenesis of these chronic disorders. He is also involved in more traditional epidemiology, and has been instrumental in defining the burden of disease associated with diabetes and its associated traits in the Asia-Pacific region. Over the past several years, Dr Tai has served on committees that write the clinical practice guidelines for the Ministry of Health in the areas lipids, diabetes mellitus and obesity. |
Keynote Lecture 5: |
Tien Yin Wong is an academic ophthalmologist and epidemiologist. He completed medical school at the National University of Singapore, and a Ph.D. in epidemiology from the Johns Hopkins University School of Public Health. He has also completed a two year American Diabetes Association post-doctoral fellowship at the University of Wisconsin, Madison. Prof Wong’s clinical and research interest is in the area of retinal vascular diseases, focused on the relationship of retinal vascular signs to risk of cardiovascular and metabolic disease, including diabetes, stroke and heart disease. He has published 300 peer-reviewed papers, including papers in the New England Journal of Medicine, the Lancet and the JAMA, andhas been awarded grants >$20 million in US, Singapore, and Australia. Prof Wong has been awarded numerous prizes, including the Outstanding Researcher Award from the National University of Singapore (2004), the Woodward Medal in Science and Technology from the University of Melbourne (2005), the Alcon Award from the Alcon Research Institute, USA (2006), the Novartis Prize in Diabetes (Young Investigator, Global) (2006), the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research, Australia (2006) and Australia Society of Medical Research AMGEN Award for “outstanding contribution to translational research”. |
Keynote Lecture 7: JAMA Articles Retinal Arteriolar Narrowing and Risk of Diabetes Mellitus in Middle-aged Persons |
